SMS Pharmaceuticals Q2 Results
- BSE: 532815
- NSE: SMSPHARMA
- ISIN: INE812G01025
- Sector: Biotechnology & Drugs
BSE
316
-4.85 (-1.51%)
-4.85 (-1.51%)Volume2.60 K
Updated: Fri 6 Feb, 2026 | 15:25:55
NSE
318-2.45 (-0.76%)
-2.45 (-0.76%)Volume1.71 L
Updated: Fri 6 Feb, 2026 | 15:40:08
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹242.43 Cr.(23.22%)
- Operating Profit₹38.34 Cr.(67.85%)
- Profit After Tax₹25.31 Cr.(79.53%)
- Operating Margin15.82%(36.22%)
Note: Comparison is on YoY basis
Quarterly - SMS Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 204.09 | 166.43 | 22.62% | 173.90 | 17.36% |
| Depreciation/ Amortization | 10.02 | 9.75 | 2.75% | 8.62 | 16.24% |
| Operating Income | 38.34 | 29.62 | 29.47% | 22.84 | 67.85% |
| Net Income | 25.31 | 20.49 | 23.53% | 14.10 | 79.53% |
| Other Operating Expenses Total | 9.25 | 7.79 | 18.68% | 9.67 | -4.34% |
| Net Income Before Taxes | 34.04 | 24.37 | 39.69% | 19.54 | 74.18% |
| Total Revenue | 242.43 | 196.05 | 23.66% | 196.75 | 23.22% |
| Selling/ General/ Admin Expenses Total | 19.25 | 18.18 | 5.86% | 17.93 | 7.40% |
| Diluted Normalized EPS | 2.84 | 2.31 | 22.94% | 1.67 | 70.06% |